News | April 11, 2022
New very-high-sensitivity rapid antigen test kits hit Australian market
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
The announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Australia and the European Union for children aged 6-11 years
Moderna's vaccine has already received regulatory approval for adults and adolescents in Australia
Pfizer is evaluating the FDA’s comments and will work with the agency to determine an appropriate path forward
Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia
The company plans to expand its portfolio in regulated markets aggressively
Subscribe To Our Newsletter & Stay Updated
